A Pilot Study of Topiramate in Childhood Absence Epilepsy
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
Limited data exist on the effectiveness of antiepileptic drugs for treatment of childhood
absence epilepsy. Preliminary data suggest that topiramate may be an effective drug for this
condition. The present study is designed to provide further evidence of the potential
effectiveness of topiramate for childhood absence epilepsy, as well as preliminary
information about a potential target dose for future study.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.